/PRNewswire/ ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy.
Highlights Capitalizes on the clean energy transition and intends to reach Real Zero carbon emissions in 2025 Plans to sell natural gas pipeline assets and use proceeds to complete all pla. . .
ThermoGenesis Holdings, Inc. (NASDAQ:THMO – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 16,900 shares, a growth of 57.9% from the March 31st total of 10,700 shares. Currently, 1.4% of the company’s stock are sold short. Based […]
ThermoGenesis Holdings, Inc. (NASDAQ:THMO – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 10,700 shares, a drop of 65.3% from the March 15th total of 30,800 shares. Currently, 1.0% of the shares of the stock are sold short. Based on […]